The Brielle at Seaview Hosts first Covid-19 Vaccine Clinic

On 1/14/2021, the first residents at The Brielle at Seaview participated in the first of three Covid-19 Vaccine clinics held on-site at the community. Through a partnership with CVS, our residents and staff received priority access to the vaccine, leading a strong step forward for our seniors and team members to continue to focus on resident safety during the pandemic.

In December, as the Pfizer and Moderna vaccines received emergency approval for distribution, The Brielle at Seaview partnered closely with our management company, Life Care Services® to prepare for on-site clinic opportunities in which residents and staff can receive both doses of the critical vaccine. This clinic marks the first of the three opportunities to receive doses of the vaccine.

Future clinic dates will align with the necessary dose timing, as indicated by the vaccine manufacturer. We are proud to provide priority access to our residents and look forward to sharing future updates with residents and families on all anticipated clinic dates as they become available.

Call us today to learn how you or a loved one can receive priority access as a resident at The Brielle at Seaview prior to our second clinic date in early-February!

With questions regarding the vaccine or our community’s response to COVID-19, click here: https://www.lcsnet.com/covid-19-update/ 



Sign up for our newsletter and be the first to learn about upcoming events at The Brielle:

  • This field is for validation purposes and should be left unchanged.

Questions?
We’re Here to Help!

With all of the decisions you need to make in choosing a senior living community, we want to make sure you and your family have the information you need. Submit a request for more information and our team will be in touch shortly.

  • Interested in a career at The Brielle? Click here.
    By providing this information, you allow The Brielle to contact you. See our Privacy Policy for more details.
  • Hidden
  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.